| Literature DB >> 29682275 |
Abstract
BACKGROUND: Follicular thyroid cancer (FTC) has historically been linked to iodine deficiency. Although Ghana is among the iodine deficient regions of the world, the proportions, trends, and the clinical features of FTCs have not been studied as a single disease entity. The aim of this study was to determine the relative frequencies, trends, and the clinicopathological characteristics of FTCs among all thyroid malignancies in our institution.Entities:
Year: 2018 PMID: 29682275 PMCID: PMC5845486 DOI: 10.1155/2018/6516035
Source DB: PubMed Journal: J Thyroid Res
Figure 1Annual Trend in FTC for the period 1994–2013.
Figure 2Age characteristics of patients diagnosed with thyroid cancers.
Demographic characteristics and the clinical presentation of FCTs in females and males.
| Female ( | Male ( |
| |
|---|---|---|---|
|
| |||
| ≤19 | 3 (6.4) | 0 (0.0) | 0.277 |
| 20–29 | 8 (17.0) | 5 (16.7) | 1.000 |
| 30–39 | 5 (10.6) | 2 (6.7) | 0.699 |
| 40–49 | 7 (14.9) | 8 (26.7) | 0.245 |
| 50–59 | 11 (23.4) | 11 (36.7) | 0.301 |
| ≥60 | 13 (27.7) | 4 (13.3) | 0.168 |
|
| |||
| Anterior neck swelling | 42 (89.4) | 26 (86.7) | 0.730 |
| Pathological fracture | 0 (0.0) | 2 (6.7) | 0.149 |
| Bone pain | 2 (4.3) | 1 (3.3) | 1.000 |
| Soft tissue swelling | 3 (6.3) | 1 (3.3) | 1.000 |
|
| |||
| 1 | 8 (25.8) | 5 (22.7) | 1.000 |
| 2 | 2 (6.5) | 4 (18.2) | 0.201 |
| 3 | 4 (12.9) | 6 (27.3) | 0.175 |
| ≥4 | 17 (52.7) | 7 (31.8) | 0.315 |
|
| |||
| Total thyroidectomy | 22 (46.8) | 14 (46.7) | 1.000 |
| Near total thyroidectomy | 5 (10.6) | 4 (13.3) | 0.730 |
| Lobectomy | 12 (25.6) | 4 (13.3) | 0.256 |
| Biopsy | 8 (17.0) | 7 (23.3) | 0.562 |
| Neck dissection | 0 (0.0) | 1 (1.3) | 0.390 |
Histological subtypes and distant spread of FTCs at the time of histological diagnosis in females and males.
| Female ( | Male ( |
| |
|---|---|---|---|
|
| |||
| Conventional | 38 (80.9) | 18 (60.0) | 0.066 |
| Hurthle cell | 5 (10.6) | 8 (26.7) | 0.116 |
| Insular | 1 (2.1) | 1 (3.3) | 1.000 |
| | 1 (2.1) | 2 (6.7) | 0.557 |
| Encapsulated | 1 (2.1) | 0 (0.0) | 1.000 |
| Uncertain malignant potential | 1 (2.1) | 1 (3.3) | 1.000 |
| Total | 47 (100.0) | 30 (100.0) | |
|
| 9 (19.1) | 7 (23.3) | 0.775 |
| Lymph node | 4 (44.4) | 2 (28.6) | 0.633 |
| Bony involvements | 1 (11.1) | 4 (57.2) | 0.106 |
| (i) Femur | 0 (0.0) | 1 (14.3) | 1.000 |
| (ii) Clavicle | 0 (0.0) | 1 (14.3) | 1.000 |
| (iii) Cervical vertebrae | 1 (11.1) | 1 (14.3) | 0.400 |
| (iv) Rib | 0 (0.0) | 1 (14.3) | 0.000 |
| Forehead (swelling) | 1 (11.1) | 0 (0.0) | 1.000 |
| Neck muscle | 2 (22.2) | 1 (14.3) | 1.000 |
| Dural mater | 1 (11.1) | 0 (0.0) | 1.000 |
| Total | 9 (100.0) | 7 (100.0) |